L194 Pill — WHITE CAPSULE, 8mm — Famotidine

No photo available
View full Famotidine profile
ImprintL194
ColourWHITE
ShapeCAPSULE
Size8
StrengthFAMOTIDINE 20 mg
Dosage formTablet
ManufacturerKmart Corporation
NDC49738-194
Schedule—
Availability—
IngredientsFAMOTIDINE[FAMOTIDINE]

What does this imprint mean?

The imprint "L194" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Famotidine

Uses and warnings

Central Nervous System Adverse Reactions: "Confusion, delirium, hallucinations, disorientation, agitation, seizures, and lethargy" have occurred in elderly patients and those with moderate-to-severe renal impairment; dosage reduction is recommended. Concurrent Gastric Malignancy: Symptom improvement does not exclude gastric cancer presence; evaluate patients with suboptimal response or early relapse. Renal Impairment Warning: QT prolongation risk exists in moderate-to-severe renal impairment patients.

Famotidine tablets treat active duodenal and gastric ulcers, symptomatic nonerosive GERD, and erosive esophagitis in patients 40 kg or greater. In adults, it also treats pathological hypersecretory conditions like Zollinger-Ellison syndrome and reduces duodenal ulcer recurrence risk.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Famotidine

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 413c7671-f223-4ab7-88da-59225771d954.xml